Literature DB >> 29320641

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON TESTING FOR AUTONOMIC AND SOMATIC NERVE DYSFUNCTION.

Aaron I Vinik, Pauline M Camacho, Jaime A Davidson, Yehuda Handelsman, Howard M Lando, Anne L Leddy, Sethu K Reddy, Richard Cook, Vicenza Spallone, Solomon Tesfaye, Dan Ziegler.   

Abstract

This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

Entities:  

Mesh:

Year:  2017        PMID: 29320641     DOI: 10.4158/EP-2017-0053

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  3 in total

Review 1.  Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.

Authors:  Vincenza Spallone
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

Review 2.  Autonomic Testing Optimizes Therapy for Heart Failure and Related Cardiovascular Disorders.

Authors:  Nicholas L DePace; Joe Colombo; Kaushik Mandal; Howard J Eisen
Journal:  Curr Cardiol Rep       Date:  2022-09-05       Impact factor: 3.955

Review 3.  Clinical spectrum and diagnosis of diabetic neuropathies.

Authors:  Jeeyoung Oh
Journal:  Korean J Intern Med       Date:  2020-08-28       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.